AI Article Synopsis
- The study aimed to investigate the prevalence of ADHD and autism spectrum disorder (ASD) in individuals with dystrophinopathy compared to the general population.
- A retrospective chart review was conducted at a neuromuscular clinic, revealing ADHD prevalence at 18.40% and ASD at 12.73%, both significantly higher than general population rates.
- The findings indicated a connection between ADHD and family history, but no significant link was found between ADHD prevalence and steroid use; future research will use validated assessments to further explore these conditions.
Article Abstract
Objective: To study the prevalence of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in individuals with dystrophinopathy compared with the general population.
Methods: Retrospective chart review to examine the prevalence of ADHD and ASD, diagnosed both formally and informally, in individuals with dystrophinopathy receiving care in the multidisciplinary neuromuscular clinic at the Ann and Robert H. Lurie Children's Hospital of Chicago.
Results: Our results demonstrate an ADHD prevalence of 18.40% and ASD prevalence of 12.73%, both significantly higher than those reported for the general population. Our results revealed a significant association between ADHD diagnosis and a positive family history but did not show a statistically significant association between prevalence of ADHD and the use of steroids.
Conclusion: Based on our current study results, we plan to further evaluate the prevalence, in a prospective cross-sectional manner, using validated screens for both ADHD and ASD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pediatrneurol.2024.05.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!